Dr. Jennifer L. Raymond's lab at Stanford University focuses on understanding how learning influences brain function, particularly in the context of sensory processing and motor control. The lab investigates how the brain's neural circuits adapt their signal processing capabilities through experience, aiming to understand fundamental processes like synaptic plasticity that can lead to improved recovery from neural disorders. By combining experimental techniques with computational models, the lab seeks to reveal insights that could innovate clinical strategies for balancing and eye movement disorders.

Dr. Inma Cobos' research lab at Stanford focuses on understanding how different brain cells respond to Alzheimer's disease. By studying humanized mouse models, the lab aims to identify which types of brain cells are especially vulnerable to the disease and how they interact with each other. Their work will help uncover the mechanisms that lead to cognitive deficits and advance the understanding of Alzheimer's pathology.

Dr. Gerald R. Crabtree's lab focuses on developing innovative small molecules to treat blood cancers, specifically Diffuse Large B Cell Lymphoma (DLBCL). They employ a unique strategy to trick cancer cells into activating their own cell death mechanisms using engineered compounds that target specific genes involved in cancer growth. This research could lead to more precise and effective cancer therapies with fewer side effects.

Dr. Martha S. Cyert's lab at Stanford University focuses on understanding how calcineurin, a crucial protein involved in calcium signaling, works at cellular membranes. The research explores how calcineurin interacts with proteins through a process called S-acylation, which involves the addition of fatty acids to proteins. This work has implications for diseases such as cancer and immune disorders, as well as a better understanding of cellular processes and potential therapeutic targets.

Dr. Jeanne Shen's lab focuses on improving treatment outcomes for colorectal cancer using advanced machine learning techniques. They are creating sophisticated models that analyze a combination of medical imaging, pathology slides, and clinical records to better predict patient risk and treatment effectiveness. The research aims to make these tools publicly available to help other researchers and clinicians enhance cancer care more broadly.

Dr. Alice Y Ting's lab focuses on developing innovative enzymes that improve the mapping of proteins within living cells. Their research aims to create more effective methods for studying how proteins interact and organize within cells, which is essential for understanding various biological processes and diseases. By enhancing existing techniques and creating new ones, the lab seeks to advance our tools for exploring cellular dynamics and potential treatments for diseases.

Daria Mochly-Rosen's lab at Stanford University focuses on understanding how certain enzymes in our bodies interact with ethanol, a common substance consumed by many. The research highlights the role of aldehyde dehydrogenases, which help detoxify harmful compounds from alcohol metabolism, and how genetic variations in these enzymes can increase the risk of health problems. By studying these enzymes, especially in different genetic backgrounds, the lab aims to uncover new insights into alcohol-related diseases and contribute to personalized medicine approaches for better health outcomes.

Dr. Robert B. West's lab at Stanford University focuses on breast cancer research, particularly the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer (IBC). The lab studies how certain immune cells, particularly macrophages, behave in the tumor microenvironment to identify new biomarkers that could predict cancer progression. Their research aims to improve our understanding of cancer biology and to better predict patient outcomes based on specific tumor characteristics.

Dr. Bianxiao Cui's lab at Stanford University focuses on important research that combines chemistry and biology to tackle major health challenges. The lab is working on innovative strategies to improve cancer treatment by targeting the unique characteristics of cancer cells, particularly how they survive during metastasis. Additionally, they are developing advanced technologies to monitor heart cell activity, which is crucial for understanding heart health and diseases. This cutting-edge research may lead to new therapies and better diagnostic tools.

Dr. Kim Butts Pauly's lab focuses on using transcranial ultrasound stimulation (TUS) as a non-invasive method to treat substance use disorders by targeting specific brain regions like the nucleus accumbens. The lab aims to improve the precision and safety of TUS in human studies while addressing the challenges of auditory effects that might interfere with results. By designing better testing methods and waveforms, the research seeks to enhance the effectiveness of TUS for neurological interventions and ultimately contribute to innovative treatments.

Dr. William S Talbot's lab at Stanford University studies glial cells in the central nervous system, particularly focusing on oligodendrocytes and microglia. Using zebrafish as a model organism, the lab investigates how these cells develop, function, and respond to various signals. The ultimate aim is to understand the genetic mechanisms underlying brain health and disease, which could lead to new treatments for neurological disorders.

Dr. Michelle Louise James's lab at Stanford University focuses on improving cancer immunotherapy, particularly through the development of imaging techniques that can track the activity of specialized T cells used in therapies like CAR T cell treatment. By creating advanced imaging agents, the lab aims to provide doctors with new tools to monitor and optimize these therapies for better patient outcomes. Their work seeks to enhance our understanding of how T cells behave in the body and improve treatment effectiveness for cancer patients.

Dr. Michael R. Howitt's lab at Stanford University focuses on understanding unique cells in the colon called tuft cells, which play a critical role in sensing infections and regulating the immune response. By studying how these cells interact with the gut microbiome, especially under the influence of different organisms, the research aims to develop insights for treating gastrointestinal disorders. The lab's work may lead to new therapies for infections and inflammation in the gut.

Professor Guillem Pratx's lab at Stanford University focuses on developing advanced tumor models that closely mimic real human cancer tissues. By using innovative technologies like microfluidics and radioluminescence microscopy, the lab aims to create personalized models of tumors from patients, which can be used for drug discovery and to improve cancer treatment. Their research is designed to enhance the capability of imaging these models, making it possible to evaluate new therapies in a way that may lead to better patient outcomes.

Dr. Laura D. Attardi's lab focuses on understanding how the p53 gene helps suppress cancer. By studying its pathways and interactions, the lab aims to identify potential new treatments for various cancers like lung adenocarcinoma and hepatocellular carcinoma. The research uses advanced techniques like CRISPR and single-cell sequencing to gain insights into cancer biology and improve therapeutic strategies.

Dr. Urban's lab at Stanford is focused on understanding the genetic variations that occur in individual cells within our bodies, a phenomenon known as somatic mosaicism. By developing and testing advanced techniques, the lab aims to accurately identify and characterize these genetic changes, which can have significant implications for understanding diseases and the biology of tissues. The work includes innovative methods to analyze the entire genome of single cells, which could lead to breakthroughs in personalized medicine.

Dr. Bali Pulendran's lab at Stanford University focuses on understanding how vaccines work, particularly in relation to COVID-19 and malaria. They use advanced techniques to investigate the immune responses induced by vaccines, taking into account factors like the microbiome and individual variations. The lab aims to identify signature patterns in immune responses that can predict how well different populations respond to vaccination, especially in children and those with specific health conditions.

Dr. Anne M Villeneuve's lab focuses on how chromosomes are accurately divided during the process of meiosis, which is essential for producing healthy eggs and sperm. By studying a small roundworm called Caenorhabditis elegans, the lab aims to uncover the important molecular and cellular processes that ensure chromosomes are inherited correctly. This research is crucial because mistakes in chromosome segregation can lead to miscarriages, birth defects, and even cancer.

Dr. Peter Sarnow's lab at Stanford University focuses on understanding how certain viruses use circular RNAs to impact infection outcomes. They investigate how these virus-derived circular RNAs, produced during infections by viruses like hepatitis C and SARS-CoV-2, might influence viral behavior and potentially lead to new antiviral strategies. This research is crucial for developing effective treatments and vaccines against viral diseases, particularly in the context of emerging viral variants and diseases.

Dr. John M. Pauly's lab focuses on developing innovative wireless technology to improve MRI receiver arrays. By eliminating cumbersome cables, their research aims to enhance image quality and make MRI technology more accessible and practical for both doctors and patients. They are working on creating lightweight, wearable MRI systems that offer non-contact vital signs monitoring and streamline patient care in medical settings.